Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
JUND
|
ENSG00000130522.4 | JunD proto-oncogene, AP-1 transcription factor subunit |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
JUND | hg19_v2_chr19_-_18391708_18391739 | 0.24 | 1.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_-_37545972 | 5.72 |
ENST00000216223.5
|
IL2RB
|
interleukin 2 receptor, beta |
chr1_+_160709029 | 4.67 |
ENST00000444090.2
ENST00000441662.2 |
SLAMF7
|
SLAM family member 7 |
chr1_-_153348067 | 4.58 |
ENST00000368737.3
|
S100A12
|
S100 calcium binding protein A12 |
chrX_+_78200829 | 4.54 |
ENST00000544091.1
|
P2RY10
|
purinergic receptor P2Y, G-protein coupled, 10 |
chr5_+_35852797 | 4.39 |
ENST00000508941.1
|
IL7R
|
interleukin 7 receptor |
chr17_-_29645836 | 4.29 |
ENST00000578584.1
|
CTD-2370N5.3
|
CTD-2370N5.3 |
chr16_+_31366536 | 4.13 |
ENST00000562522.1
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr2_+_169926047 | 3.56 |
ENST00000428522.1
ENST00000450153.1 ENST00000421653.1 |
DHRS9
|
dehydrogenase/reductase (SDR family) member 9 |
chr1_+_117297007 | 3.52 |
ENST00000369478.3
ENST00000369477.1 |
CD2
|
CD2 molecule |
chr1_+_160709076 | 3.51 |
ENST00000359331.4
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
chr1_+_160709055 | 3.50 |
ENST00000368043.3
ENST00000368042.3 ENST00000458602.2 ENST00000458104.2 |
SLAMF7
|
SLAM family member 7 |
chr21_+_42742429 | 3.38 |
ENST00000418103.1
|
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr6_-_24936170 | 3.28 |
ENST00000538035.1
|
FAM65B
|
family with sequence similarity 65, member B |
chr12_-_68553512 | 3.27 |
ENST00000229135.3
|
IFNG
|
interferon, gamma |
chr3_+_46412345 | 3.10 |
ENST00000292303.4
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene) |
chr10_+_49892904 | 2.94 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
chr14_-_25103472 | 2.89 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr14_-_25103388 | 2.75 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr16_+_23847339 | 2.72 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr16_+_31366455 | 2.69 |
ENST00000268296.4
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
chr15_+_89182178 | 2.63 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr15_+_89182156 | 2.60 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr1_+_26605618 | 2.53 |
ENST00000270792.5
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr22_-_36761081 | 2.43 |
ENST00000456729.1
ENST00000401701.1 |
MYH9
|
myosin, heavy chain 9, non-muscle |
chrY_+_15016725 | 2.42 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr3_-_18466026 | 2.41 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
chr22_+_22749343 | 2.39 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr2_-_231789941 | 2.36 |
ENST00000392040.1
ENST00000438398.1 |
GPR55
|
G protein-coupled receptor 55 |
chr15_+_89181974 | 2.32 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chrX_-_70326455 | 2.31 |
ENST00000374251.5
|
CXorf65
|
chromosome X open reading frame 65 |
chr6_-_41673552 | 2.28 |
ENST00000419574.1
ENST00000445214.1 |
TFEB
|
transcription factor EB |
chr12_+_9142131 | 2.28 |
ENST00000356986.3
ENST00000266551.4 |
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr4_-_84035868 | 2.23 |
ENST00000426923.2
ENST00000509973.1 |
PLAC8
|
placenta-specific 8 |
chr18_-_74207146 | 2.18 |
ENST00000443185.2
|
ZNF516
|
zinc finger protein 516 |
chr2_-_145275211 | 2.17 |
ENST00000462355.1
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr6_+_132455526 | 2.07 |
ENST00000443303.1
|
LINC01013
|
long intergenic non-protein coding RNA 1013 |
chr12_+_54891495 | 2.06 |
ENST00000293373.6
|
NCKAP1L
|
NCK-associated protein 1-like |
chr16_+_85936295 | 2.03 |
ENST00000563180.1
ENST00000564617.1 ENST00000564803.1 |
IRF8
|
interferon regulatory factor 8 |
chr16_+_28996364 | 2.02 |
ENST00000564277.1
|
LAT
|
linker for activation of T cells |
chr4_-_84035905 | 2.00 |
ENST00000311507.4
|
PLAC8
|
placenta-specific 8 |
chr14_+_22978168 | 1.96 |
ENST00000390505.1
|
TRAJ32
|
T cell receptor alpha joining 32 |
chr16_+_28996114 | 1.96 |
ENST00000395461.3
|
LAT
|
linker for activation of T cells |
chr7_+_79998864 | 1.96 |
ENST00000435819.1
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chrX_-_154493791 | 1.94 |
ENST00000369454.3
|
RAB39B
|
RAB39B, member RAS oncogene family |
chr17_-_28257080 | 1.93 |
ENST00000579954.1
ENST00000540801.1 ENST00000269033.3 ENST00000590153.1 ENST00000582084.1 |
SSH2
|
slingshot protein phosphatase 2 |
chr1_+_223889310 | 1.89 |
ENST00000434648.1
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr19_+_35820064 | 1.80 |
ENST00000341773.6
ENST00000600131.1 ENST00000270311.6 ENST00000595780.1 ENST00000597916.1 ENST00000593867.1 ENST00000600424.1 ENST00000599811.1 ENST00000536635.2 ENST00000085219.5 ENST00000544992.2 ENST00000419549.2 |
CD22
|
CD22 molecule |
chr19_-_19739321 | 1.77 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chr13_-_30160925 | 1.75 |
ENST00000450494.1
|
SLC7A1
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
chr6_+_63921351 | 1.73 |
ENST00000370659.1
|
FKBP1C
|
FK506 binding protein 1C |
chr1_+_223889285 | 1.65 |
ENST00000433674.2
|
CAPN2
|
calpain 2, (m/II) large subunit |
chr11_+_59856130 | 1.62 |
ENST00000278888.3
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2 |
chr1_-_235116495 | 1.60 |
ENST00000549744.1
|
RP11-443B7.3
|
RP11-443B7.3 |
chr22_+_23101182 | 1.57 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr12_-_76817036 | 1.56 |
ENST00000546946.1
|
OSBPL8
|
oxysterol binding protein-like 8 |
chr21_+_42733870 | 1.55 |
ENST00000330714.3
ENST00000436410.1 ENST00000435611.1 |
MX2
|
myxovirus (influenza virus) resistance 2 (mouse) |
chr22_+_22707260 | 1.54 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr12_-_8218926 | 1.47 |
ENST00000546241.1
|
C3AR1
|
complement component 3a receptor 1 |
chr21_-_35340759 | 1.44 |
ENST00000607953.1
|
AP000569.9
|
AP000569.9 |
chr17_+_65375082 | 1.43 |
ENST00000584471.1
|
PITPNC1
|
phosphatidylinositol transfer protein, cytoplasmic 1 |
chr11_-_66103867 | 1.42 |
ENST00000424433.2
|
RIN1
|
Ras and Rab interactor 1 |
chr5_-_141061759 | 1.37 |
ENST00000508305.1
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr11_-_66104237 | 1.37 |
ENST00000530056.1
|
RIN1
|
Ras and Rab interactor 1 |
chr17_-_73150629 | 1.37 |
ENST00000356033.4
ENST00000405458.3 ENST00000409753.3 |
HN1
|
hematological and neurological expressed 1 |
chr2_+_181988560 | 1.35 |
ENST00000424170.1
ENST00000435411.1 |
AC104820.2
|
AC104820.2 |
chr12_-_8218997 | 1.35 |
ENST00000307637.4
|
C3AR1
|
complement component 3a receptor 1 |
chr2_-_145275109 | 1.35 |
ENST00000431672.2
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr4_-_123377880 | 1.34 |
ENST00000226730.4
|
IL2
|
interleukin 2 |
chr5_-_140013224 | 1.32 |
ENST00000498971.2
|
CD14
|
CD14 molecule |
chr5_-_140013275 | 1.32 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr17_-_45899126 | 1.31 |
ENST00000007414.3
ENST00000392507.3 |
OSBPL7
|
oxysterol binding protein-like 7 |
chr16_-_67281413 | 1.30 |
ENST00000258201.4
|
FHOD1
|
formin homology 2 domain containing 1 |
chr3_-_150996239 | 1.28 |
ENST00000309170.3
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr19_-_29026154 | 1.27 |
ENST00000593065.1
|
AC005307.3
|
AC005307.3 |
chr17_-_38928414 | 1.25 |
ENST00000335552.4
|
KRT26
|
keratin 26 |
chr5_-_141061777 | 1.25 |
ENST00000239440.4
|
ARAP3
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
chr8_-_135522425 | 1.25 |
ENST00000521673.1
|
ZFAT
|
zinc finger and AT hook domain containing |
chr11_-_66103932 | 1.25 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
chr21_+_30672433 | 1.22 |
ENST00000451655.1
|
BACH1
|
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
chr10_+_17270214 | 1.22 |
ENST00000544301.1
|
VIM
|
vimentin |
chr19_-_54872556 | 1.22 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr12_-_95010147 | 1.19 |
ENST00000548918.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr14_+_73525265 | 1.19 |
ENST00000525161.1
|
RBM25
|
RNA binding motif protein 25 |
chr20_+_30946106 | 1.18 |
ENST00000375687.4
ENST00000542461.1 |
ASXL1
|
additional sex combs like 1 (Drosophila) |
chr15_+_75335604 | 1.17 |
ENST00000563393.1
|
PPCDC
|
phosphopantothenoylcysteine decarboxylase |
chr6_+_149539767 | 1.15 |
ENST00000606202.1
ENST00000536230.1 ENST00000445901.1 |
TAB2
RP1-111D6.3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 RP1-111D6.3 |
chr10_-_50396357 | 1.14 |
ENST00000453436.1
ENST00000474718.1 |
C10orf128
|
chromosome 10 open reading frame 128 |
chr12_-_95009837 | 1.12 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr13_-_31038370 | 1.07 |
ENST00000399489.1
ENST00000339872.4 |
HMGB1
|
high mobility group box 1 |
chr1_-_203273676 | 1.05 |
ENST00000425698.1
|
RP11-134P9.1
|
long intergenic non-protein coding RNA 1136 |
chr5_-_140013241 | 1.04 |
ENST00000519715.1
|
CD14
|
CD14 molecule |
chr18_-_74839891 | 1.02 |
ENST00000581878.1
|
MBP
|
myelin basic protein |
chr3_-_105588231 | 1.02 |
ENST00000545639.1
ENST00000394027.3 ENST00000438603.1 ENST00000447441.1 ENST00000443752.1 |
CBLB
|
Cbl proto-oncogene B, E3 ubiquitin protein ligase |
chr12_+_62654119 | 1.00 |
ENST00000353364.3
ENST00000549523.1 ENST00000280377.5 |
USP15
|
ubiquitin specific peptidase 15 |
chr15_+_67420441 | 1.00 |
ENST00000558894.1
|
SMAD3
|
SMAD family member 3 |
chr19_+_35810164 | 0.99 |
ENST00000598537.1
|
CD22
|
CD22 molecule |
chrX_-_153718953 | 0.98 |
ENST00000369649.4
ENST00000393586.1 |
SLC10A3
|
solute carrier family 10, member 3 |
chr3_-_69402828 | 0.95 |
ENST00000460709.1
|
FRMD4B
|
FERM domain containing 4B |
chr14_-_23426322 | 0.93 |
ENST00000555367.1
|
HAUS4
|
HAUS augmin-like complex, subunit 4 |
chr14_+_22977587 | 0.93 |
ENST00000390504.1
|
TRAJ33
|
T cell receptor alpha joining 33 |
chr14_-_23426231 | 0.92 |
ENST00000556915.1
|
HAUS4
|
HAUS augmin-like complex, subunit 4 |
chr7_-_33080506 | 0.92 |
ENST00000381626.2
ENST00000409467.1 ENST00000449201.1 |
NT5C3A
|
5'-nucleotidase, cytosolic IIIA |
chr5_+_169758393 | 0.91 |
ENST00000521471.1
ENST00000518357.1 ENST00000436248.3 |
CTB-114C7.3
|
CTB-114C7.3 |
chr18_+_74207477 | 0.89 |
ENST00000532511.1
|
RP11-17M16.1
|
uncharacterized protein LOC400658 |
chr4_-_123542224 | 0.89 |
ENST00000264497.3
|
IL21
|
interleukin 21 |
chr17_+_25799008 | 0.88 |
ENST00000583370.1
ENST00000398988.3 ENST00000268763.6 |
KSR1
|
kinase suppressor of ras 1 |
chr14_-_23426270 | 0.87 |
ENST00000557591.1
ENST00000397409.4 ENST00000490506.1 ENST00000554406.1 |
HAUS4
|
HAUS augmin-like complex, subunit 4 |
chr1_-_36020531 | 0.87 |
ENST00000440579.1
ENST00000494948.1 |
KIAA0319L
|
KIAA0319-like |
chr3_+_30647994 | 0.86 |
ENST00000295754.5
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa) |
chr11_-_82708435 | 0.86 |
ENST00000525117.1
ENST00000532548.1 |
RAB30
|
RAB30, member RAS oncogene family |
chr17_+_57807062 | 0.86 |
ENST00000587259.1
|
VMP1
|
vacuole membrane protein 1 |
chr8_-_74659693 | 0.85 |
ENST00000518767.1
|
STAU2
|
staufen double-stranded RNA binding protein 2 |
chr3_-_52713729 | 0.84 |
ENST00000296302.7
ENST00000356770.4 ENST00000337303.4 ENST00000409057.1 ENST00000410007.1 ENST00000409114.3 ENST00000409767.1 ENST00000423351.1 |
PBRM1
|
polybromo 1 |
chr10_-_81708854 | 0.84 |
ENST00000372292.3
|
SFTPD
|
surfactant protein D |
chr16_+_29127282 | 0.81 |
ENST00000562902.1
|
RP11-426C22.5
|
RP11-426C22.5 |
chr6_+_63921399 | 0.81 |
ENST00000356170.3
|
FKBP1C
|
FK506 binding protein 1C |
chr1_-_67266939 | 0.81 |
ENST00000304526.2
|
INSL5
|
insulin-like 5 |
chr14_-_23426337 | 0.81 |
ENST00000342454.8
ENST00000555986.1 ENST00000541587.1 ENST00000554516.1 ENST00000347758.2 ENST00000206474.7 ENST00000555040.1 |
HAUS4
|
HAUS augmin-like complex, subunit 4 |
chr1_+_28527070 | 0.80 |
ENST00000596102.1
|
AL353354.2
|
AL353354.2 |
chr15_+_42566384 | 0.79 |
ENST00000440615.2
ENST00000318010.8 |
GANC
|
glucosidase, alpha; neutral C |
chr3_-_155011483 | 0.79 |
ENST00000489090.1
|
RP11-451G4.2
|
RP11-451G4.2 |
chr3_-_150996146 | 0.79 |
ENST00000494668.1
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14 |
chr6_+_145118873 | 0.78 |
ENST00000432686.1
ENST00000417142.1 |
UTRN
|
utrophin |
chr22_-_43398442 | 0.77 |
ENST00000422336.1
|
PACSIN2
|
protein kinase C and casein kinase substrate in neurons 2 |
chr4_-_178169927 | 0.75 |
ENST00000512516.1
|
RP11-487E13.1
|
Uncharacterized protein |
chr12_+_62654155 | 0.75 |
ENST00000312635.6
ENST00000393654.3 ENST00000549237.1 |
USP15
|
ubiquitin specific peptidase 15 |
chr15_-_51535208 | 0.74 |
ENST00000405913.3
ENST00000559878.1 |
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1 |
chr5_+_145583107 | 0.74 |
ENST00000506502.1
|
RBM27
|
RNA binding motif protein 27 |
chr5_-_60140009 | 0.73 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr1_+_198189921 | 0.73 |
ENST00000391974.3
|
NEK7
|
NIMA-related kinase 7 |
chr2_+_102615416 | 0.72 |
ENST00000393414.2
|
IL1R2
|
interleukin 1 receptor, type II |
chr10_-_31288398 | 0.70 |
ENST00000538351.2
|
ZNF438
|
zinc finger protein 438 |
chr10_-_30024716 | 0.70 |
ENST00000375398.2
ENST00000375400.3 |
SVIL
|
supervillin |
chr19_+_11546093 | 0.68 |
ENST00000591462.1
|
PRKCSH
|
protein kinase C substrate 80K-H |
chr21_+_26934165 | 0.67 |
ENST00000456917.1
|
MIR155HG
|
MIR155 host gene (non-protein coding) |
chr18_-_5419797 | 0.66 |
ENST00000542146.1
ENST00000427684.2 |
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3 |
chr3_+_127770455 | 0.66 |
ENST00000464451.1
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae) |
chr3_-_49395705 | 0.63 |
ENST00000419349.1
|
GPX1
|
glutathione peroxidase 1 |
chr4_-_104119528 | 0.62 |
ENST00000380026.3
ENST00000503705.1 ENST00000265148.3 |
CENPE
|
centromere protein E, 312kDa |
chr17_-_7590745 | 0.59 |
ENST00000514944.1
ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53
|
tumor protein p53 |
chr5_+_145583156 | 0.57 |
ENST00000265271.5
|
RBM27
|
RNA binding motif protein 27 |
chr14_-_24711470 | 0.56 |
ENST00000559969.1
|
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr12_-_102591604 | 0.56 |
ENST00000329406.4
|
PMCH
|
pro-melanin-concentrating hormone |
chr7_+_100663353 | 0.54 |
ENST00000306151.4
|
MUC17
|
mucin 17, cell surface associated |
chr11_-_6008215 | 0.54 |
ENST00000332249.4
|
OR52L1
|
olfactory receptor, family 52, subfamily L, member 1 |
chr4_-_100356551 | 0.53 |
ENST00000209665.4
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr14_+_58765305 | 0.53 |
ENST00000445108.1
|
ARID4A
|
AT rich interactive domain 4A (RBP1-like) |
chr5_+_147582348 | 0.51 |
ENST00000514389.1
|
SPINK6
|
serine peptidase inhibitor, Kazal type 6 |
chr17_+_7590734 | 0.50 |
ENST00000457584.2
|
WRAP53
|
WD repeat containing, antisense to TP53 |
chr1_+_41204506 | 0.50 |
ENST00000525290.1
ENST00000530965.1 ENST00000416859.2 ENST00000308733.5 |
NFYC
|
nuclear transcription factor Y, gamma |
chr5_-_60140089 | 0.49 |
ENST00000507047.1
ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr10_-_50396407 | 0.48 |
ENST00000374153.2
ENST00000374151.3 |
C10orf128
|
chromosome 10 open reading frame 128 |
chr2_+_75145275 | 0.47 |
ENST00000435984.1
|
AC104135.3
|
AC104135.3 |
chr14_+_58765103 | 0.47 |
ENST00000355431.3
ENST00000348476.3 ENST00000395168.3 |
ARID4A
|
AT rich interactive domain 4A (RBP1-like) |
chr15_+_42565464 | 0.47 |
ENST00000562170.1
ENST00000562859.1 |
GANC
|
glucosidase, alpha; neutral C |
chr22_-_39097527 | 0.47 |
ENST00000417712.1
|
JOSD1
|
Josephin domain containing 1 |
chr7_-_15014398 | 0.46 |
ENST00000437998.1
|
DGKB
|
diacylglycerol kinase, beta 90kDa |
chr11_-_102826434 | 0.45 |
ENST00000340273.4
ENST00000260302.3 |
MMP13
|
matrix metallopeptidase 13 (collagenase 3) |
chr3_-_122512619 | 0.45 |
ENST00000383659.1
ENST00000306103.2 |
HSPBAP1
|
HSPB (heat shock 27kDa) associated protein 1 |
chr11_-_82708519 | 0.45 |
ENST00000534301.1
|
RAB30
|
RAB30, member RAS oncogene family |
chr8_+_128426535 | 0.42 |
ENST00000465342.2
|
POU5F1B
|
POU class 5 homeobox 1B |
chr5_-_41794663 | 0.42 |
ENST00000510634.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr15_+_42565844 | 0.41 |
ENST00000566442.1
|
GANC
|
glucosidase, alpha; neutral C |
chr12_-_95510743 | 0.41 |
ENST00000551521.1
|
FGD6
|
FYVE, RhoGEF and PH domain containing 6 |
chrX_-_111923145 | 0.41 |
ENST00000371968.3
ENST00000536453.1 |
LHFPL1
|
lipoma HMGIC fusion partner-like 1 |
chr17_-_59668550 | 0.40 |
ENST00000521764.1
|
NACA2
|
nascent polypeptide-associated complex alpha subunit 2 |
chr9_-_39239171 | 0.39 |
ENST00000358144.2
|
CNTNAP3
|
contactin associated protein-like 3 |
chr10_-_50396425 | 0.39 |
ENST00000374148.1
|
C10orf128
|
chromosome 10 open reading frame 128 |
chr1_-_6662919 | 0.39 |
ENST00000377658.4
ENST00000377663.3 |
KLHL21
|
kelch-like family member 21 |
chr15_-_42565606 | 0.38 |
ENST00000307216.6
ENST00000448392.1 |
TMEM87A
|
transmembrane protein 87A |
chr14_+_73525144 | 0.37 |
ENST00000261973.7
ENST00000540173.1 |
RBM25
|
RNA binding motif protein 25 |
chrX_+_22056165 | 0.37 |
ENST00000535894.1
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked |
chr1_-_205053645 | 0.37 |
ENST00000367167.3
|
TMEM81
|
transmembrane protein 81 |
chr6_-_44281043 | 0.36 |
ENST00000244571.4
|
AARS2
|
alanyl-tRNA synthetase 2, mitochondrial |
chr1_-_154941350 | 0.36 |
ENST00000444179.1
ENST00000414115.1 |
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr14_+_73525229 | 0.36 |
ENST00000527432.1
ENST00000531500.1 ENST00000525321.1 ENST00000526754.1 |
RBM25
|
RNA binding motif protein 25 |
chr1_-_11918988 | 0.36 |
ENST00000376468.3
|
NPPB
|
natriuretic peptide B |
chr4_-_100356291 | 0.36 |
ENST00000476959.1
ENST00000482593.1 |
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr7_+_132937820 | 0.35 |
ENST00000393161.2
ENST00000253861.4 |
EXOC4
|
exocyst complex component 4 |
chr1_-_205744574 | 0.33 |
ENST00000367139.3
ENST00000235932.4 ENST00000437324.2 ENST00000414729.1 |
RAB7L1
|
RAB7, member RAS oncogene family-like 1 |
chr10_-_74114714 | 0.33 |
ENST00000338820.3
ENST00000394903.2 ENST00000444643.2 |
DNAJB12
|
DnaJ (Hsp40) homolog, subfamily B, member 12 |
chr12_-_27924209 | 0.33 |
ENST00000381273.3
|
MANSC4
|
MANSC domain containing 4 |
chr3_+_130150307 | 0.32 |
ENST00000512836.1
|
COL6A5
|
collagen, type VI, alpha 5 |
chr7_-_57207571 | 0.32 |
ENST00000331162.4
|
ZNF479
|
zinc finger protein 479 |
chr12_-_8765446 | 0.31 |
ENST00000537228.1
ENST00000229335.6 |
AICDA
|
activation-induced cytidine deaminase |
chr5_-_41794313 | 0.30 |
ENST00000512084.1
|
OXCT1
|
3-oxoacid CoA transferase 1 |
chr4_+_95128996 | 0.30 |
ENST00000457823.2
|
SMARCAD1
|
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 |
chr2_+_161993465 | 0.30 |
ENST00000457476.1
|
TANK
|
TRAF family member-associated NFKB activator |
chr10_+_17686193 | 0.29 |
ENST00000377500.1
|
STAM
|
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
chr11_+_59522837 | 0.29 |
ENST00000437946.2
|
STX3
|
syntaxin 3 |
chr1_-_153935738 | 0.29 |
ENST00000417348.1
|
SLC39A1
|
solute carrier family 39 (zinc transporter), member 1 |
chr1_-_153513170 | 0.28 |
ENST00000368717.2
|
S100A5
|
S100 calcium binding protein A5 |
chr17_+_1936687 | 0.28 |
ENST00000570477.1
|
DPH1
|
diphthamide biosynthesis 1 |
chr10_-_75008620 | 0.27 |
ENST00000372950.4
|
DNAJC9
|
DnaJ (Hsp40) homolog, subfamily C, member 9 |
chr1_-_153521597 | 0.27 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr2_+_36923830 | 0.27 |
ENST00000379242.3
ENST00000389975.3 |
VIT
|
vitrin |
chr4_-_68829226 | 0.27 |
ENST00000396188.2
|
TMPRSS11A
|
transmembrane protease, serine 11A |
chr3_+_191046810 | 0.26 |
ENST00000392455.3
ENST00000392456.3 |
CCDC50
|
coiled-coil domain containing 50 |
chr7_+_33765593 | 0.26 |
ENST00000311067.3
|
RP11-89N17.1
|
HCG1643653; Uncharacterized protein |
chr10_+_17686221 | 0.26 |
ENST00000540523.1
|
STAM
|
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 7.5 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
1.1 | 3.3 | GO:2000309 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
0.7 | 5.7 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 5.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.7 | 2.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.5 | 3.7 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.5 | 2.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.5 | 2.4 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 1.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 3.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.4 | 4.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 1.2 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.4 | 3.5 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 3.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.3 | 3.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.3 | 0.6 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.3 | 4.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.3 | 0.9 | GO:0002663 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.3 | 1.1 | GO:0032072 | plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) |
0.2 | 1.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 6.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.2 | 4.9 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.2 | 0.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.2 | 0.6 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.7 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.2 | 1.7 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.2 | 0.7 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.2 | 4.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 2.0 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 1.0 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.2 | 2.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.2 | 0.5 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.2 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.0 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 3.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 2.4 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 2.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 1.0 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 12.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 2.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.1 | 1.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.1 | 0.4 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.7 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 1.3 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 4.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.6 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.1 | 1.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.1 | 0.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.8 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 6.8 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.1 | 1.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 0.6 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.4 | GO:1904383 | response to sodium phosphate(GO:1904383) |
0.1 | 0.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 1.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 4.0 | GO:0002279 | mast cell activation involved in immune response(GO:0002279) mast cell mediated immunity(GO:0002448) mast cell degranulation(GO:0043303) |
0.1 | 1.0 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.1 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 1.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.8 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 2.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 2.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 1.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.7 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 1.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 2.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
0.0 | 2.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 2.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 1.9 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.4 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.0 | 6.5 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 1.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 3.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 1.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.3 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.9 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.9 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
0.0 | 0.3 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.4 | 3.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 2.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 3.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 4.9 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 9.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 6.8 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 0.6 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.1 | 8.1 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 1.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.6 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.1 | 0.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 0.4 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.6 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 1.3 | GO:0032059 | bleb(GO:0032059) |
0.1 | 3.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.8 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 14.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 2.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.0 | 4.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 4.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.7 | GO:0033270 | paranode region of axon(GO:0033270) |
0.0 | 2.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 5.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.8 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 2.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 1.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 1.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
2.2 | 4.4 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.1 | 5.7 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.7 | 2.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.5 | 3.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 2.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 4.4 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.3 | 2.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.2 | 5.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 6.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 0.9 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 2.8 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 1.7 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.2 | 0.9 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 2.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 1.7 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.6 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.8 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.1 | 1.0 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 1.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.4 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 2.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.4 | GO:0008526 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 1.2 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 2.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 2.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 4.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.6 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.6 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 4.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 1.2 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.3 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.0 | 10.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.7 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 1.9 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 2.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.4 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.5 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 1.2 | GO:0043621 | protein self-association(GO:0043621) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 1.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 4.5 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.6 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 1.0 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.0 | 4.8 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 3.2 | GO:0005125 | cytokine activity(GO:0005125) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 6.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 5.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 6.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 4.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 7.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 2.0 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 4.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 2.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 1.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 2.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 3.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 3.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 6.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.2 | 3.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 4.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.2 | 6.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 7.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 4.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 14.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 6.0 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 10.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 4.0 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 2.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.9 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 1.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 8.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 1.7 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 2.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |